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Abstract
Backgrounds: ESCC is a life-threatening disease due to invasion and metastasis in the early stage. Great efforts had
been made to detect the molecular mechanisms which led to the invasion and metastasis in ESCC. Recent
evidence had suggested that deregulation of miR-424-5p took an important role in cancers. However, its role
and functional mechanism in ESCC had seldom been elucidated.
Methods: The expression levels of miR-424-5p were detected in ESCC tissues and cell lines by real-time PCR methods.
Then, the invasion, metastasis and proliferation ability of ESCC cell lines transfected with miR-424-5p mimics were
analyzed separately by transwell invasion assay, wound healing assay and cell proliferation assay. Finally, the target
gene of miR-424-5p was studied and verified by luciferase activity assay. And the role of miR-424-5p in EMT was
also investigated by real-time PCR and western blot assay.
Results: We showed that the expression levels of miR-424-5p were decreased both in ESCC tissues and cell lines.
Furthermore, the expression levels of miR-424-5p were negatively linked to lymph node metastasis in ESCC tissues.
Restoration of miR-424-5p in EC-1 cells by using miR-424-5p mimics could decrease the invasion, metastasis and
proliferation of EC-1 cells, indicating its role in inhibition on the invasion and metastasis ability of ESCC cells and tissues.
In addition, we demonstrated that SMAD7 was a specific target gene for miR-424-5p by luciferase activity assay and
miR-424-5p could not only negatively regulate SMAD7 expression but also participate in EMT via SMAD7, because
overexpression of SMAD7 could partly enhance the miR-424-5p anti-EMT function.
Conclusions: Our results described that miR-424-5p -SMAD7 pathway contributed to ESCC invasion and metastasis
and up-regulation of miR-424-5p perhaps provided a strategy for preventing tumor invasion, metastasis.
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Esophageal squamous cell carcinoma (ESCC) is one of
the frequently occurring digestive malignant diseases in
China [1, 2]. Patients with ESCC have higher mortality
rates and 5-year survival rate is lower mainly because of
local invasion, lymph node and distant metastasis [1].
Precise mechanisms of ESCC invasion and metastasis re-
main unclear, so further studies on the potential mecha-
nisms involved in invasion and metastasis are critical for
the improvement of prognosis for patients with ESCC.
MicroRNAs are about 22 nucleotides non-coding RNAs
which can attach to their target mRNAs’ 3’UTR, by this
way, to regulate the translation and stability of the target
mRNAs through the action of the RNA-induced silencing
complex [3–5]. In many kinds of cancers including ESCC,
abnormal expression of microRNAs has been found. Fur-
thermore, the abnormal expression of microRNAs has
also been shown to be associated with tumor development
[6, 7]. In addition, abnormal microRNAs expression has
also been implicated in affecting metastatic and progres-
sion stage of cancers by the acquisition of metastatic
potential [8–10].
MiR-424-5p is located on human chromosome Xq26.3,
and recently has been classified in a large cluster together
with miR-15/miR-16 [11]. However the expression of
MiR-424-5p in different types of tumors suggested un-
equal roles. Zhang et al had demonstrated that miR-424-
5p expression was significantly reduced in the liver cancer
tissues compared with that of the corresponding non-
cancerous liver tissues and down regulation of miR-424-
5p in HCC tissues was also related to advanced disease
progression in HCC patients [12]. While, Wu et al showed
that miR-424-5p was significantly up regulated in pancre-
atic cancer [13].
Until now, great efforts had been made to identify the
association between microRNAs expression and ESCC
and to understand the functional role and molecular
mechanism of aberrant-expressed microRNAs [14, 15].
The potential of some candidate microRNAs for clinical
diagnosis and prognosis was revealed, and treatments
involving microRNAs achieved some amazing curative
effects in cancer disease models [16, 17]. However, the
expression levels and role of miR-424-5p in ESCC had
not been fully elucidated. Here, our findings provided
evidence that miR-424-5p was a tumor suppressor gene
in ESCC. Furthermore, we found that miR-424-5p
perhaps played its role through negatively regulating
SMAD7 signaling pathway. Taken together, miR-424-5p
rescue might be a rational for diagnostic and therapeutic
applications in ESCC.
Methods
Patients and tissue samples
Thirty-two pairs of ESCC tumor and adjacent normal
mucosa in paraffin-embedded blocks were acquired from
the First Affiliated Hospital of Zhengzhou University.
No patients had received radiation therapy or chemother-
apy before surgery. Two senior pathologists made and
agreed upon the histological diagnosis of ESCC tissues.
The paired ESCC tumor and adjacent normal mucosa
areas of block were carefully dissected and transferred to
RNase-free tube for RNA extraction.
Cell culture and transfection
Esophageal squamous cell lines: EC9706, Eca109, EC-1
and immortal embryonic esophageal epithelium: SHEE
cells were all cultivated in RPMI-1640 medium with
10 % FCS, at 37 °C in a 5 % CO2 humidified incubator.
RPMI-1640 medium was replaced every 2–3 days.
Transfection was typically carried out on cells that were
80 % confluent. Mature miR-424-5p mimics or control
oligotides were purchased from Dharmacon Inc. 50 nM
miR-424-5p mimics were transfected into EC-1 cells
using Lipofectamine™ 2000 (Invitrogen) according to the
manufacturer’s protocol. At the same time, EC-1 cells
transfected with control oligotides or vacant EC-1 cells
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were used as negative or blank controls respectively.
PcDNA3.1-SMAD7 transfection was done after the EC-1
cells trsfected with miR-424-5p mimics or control oligo-
tides, EC-1 cells transfected with miR-424-5p mimics,
pcDNA3.1-SMAD7 separately or vacant EC-1 cells were
used as controls.
RNA extraction
Total RNA, including microRNA was extracted from
tumor and corresponding normal tissue in paraffin-
embedded blocks using either TriReagent or mirVana
miRNA isolation Kit according to the manufacturers
protocol. The RNA was resuspended in 20 μl RNase-free
water and stored at −20 °C. The quantity and quality of
RNA were assessed by spectrophotometric and standard
electrophoresis methods.
Reverse transcription and real-time PCR
To examine the levels of miR-424-5p expression, Taq-
Man® miRNA Reverse Transcription kit were used to
generate cDNA from miRNAs. Quantitative real-time
PCR methods were used to measure the expression level
of miR-424-5p using the TaqMan® MicroRNA Assay
protocol specific for miR-424-5p. Relative expression
values of miR-424-5p were calculated by the CT-based
calibrated standard curve method. RNU6B miScript
Primer Assay was used as an endogenous control. All of
the experiments were done in triplicate.
To quantify the mRNA expression of SMAD7, vimentin,
E-cadherin, transScript First-strand cDNA Synthesis Super-
Mix kit were used to generated cDNA from total RNA.
Quantitative real-time PCR were then conducted using
STBR Premix Ex Taq™ kit with the following primers:
SMAD7 sense: GGAGTGGGGAGGAGTGAGTA, anti-
sense: TCTTTTGTGGCCCACGTCTC; E-cadherin sense:
ATGCTGATGCCCCCAATACC, antisense: GCTGTGAG
GATGCCAGTTTC; vimentin sense: GGACCAGCTAACC
AACGACA, antisense: AAGGTCAAGACGTGCCAGAG;
β-actin sense: CTGAGGCTCTTTTCCAGCCT, antisense:
CGCTCAGGAGGAGCAATGAT. The CT values were de-
termined by setting a fixed threshold. The relative amount
of mRNA was normalized to β-actin. All of the experiments
were done in triplicate.
Western blot assay
EC-1 cells in different groups were harvested and lysed
for protein extraction. The concentration of protein was
calculated with a BCA protein assay kit. Fifty microgram
proteins were separated by SDS-PAGE, and the proteins
were transferred by electro method to PVDF mem-
branes. Subsequently, the PVDF membrane was blocked
in 5 % fat-free milk for 2 h. Then, the PVDF membrane
was incubated with the primary antibody against SAMD7,
vimentin, E-cadherin and β-actin at 4 °C overnight. After
that, the PVDF membrane were washed, and incubated
with horseradish peroxidase-labelled secondary antibody
for 1 h. After exposure and development, the protein ex-
pression was analyzed using a gel imaging analysis system.
The Western blot assay was in triplicate.
Transwell invasion assay
The invasion ability of EC-1 cells was measured by
transwell invasion assay. Briefly, EC-1 cells in different
groups cultivated with RPMI-1640 medium without FCS
were put on the upper chamber coated with Matrigel.
RPMI-1640 medium with 20 % FCS as chemoattractants
were put to the lower chamber of the 24-well pates.
After 48 h incubation, cotton swabs were used to wipe
off the cells from the upper chamber. The number of
cells migrating to the lower chamber was calculated by
inverted microscopy after hematoxylin and eosin (HE)
staining. And the number of and the mean of number of
cells in each field represented the invasive ability of the
cells. All of the experiments were done in triplicate.
Wound healing assay
EC-1 cells were seeded into 12-well plates and cultured to
70 % confluence. One millimeter width wounds were
made with a plastic tip, and EC-1 cells were cultivated in a
serum-free RPMI-1640 medium. EC-1 cells migrated into
wound place, then after 48 h the average distance of mi-
grating cells was measured under an inverted microscopy.
Cell proliferation assay
Cell proliferation ability was measured using the MTT
assay. In brief, cells were placed into 96-well plates (BD
Biosciences) at a cell density of 1 × 103 cells/well in
growth medium. 24, 48 and 72 h after transfection,
100 μl of fresh serum-free RPMI-1640 medium with
0.5 g/l MTT replaced RPMI-1640 medium in each well.
After incubation for 4 h at 37 °C, the MTT medium was
removed and 50 μl of DMSO was added to each well.
The staining intensity in each group was measured by
detecting the absorbance at 450 nm. All of the experi-
ments were done in triplicate.
Luciferase activity assay
The pmir-REPORT system was used to determine whether
SMAD7 was a target of miR-424-5p. The wild-type
SMAD7 3’UTR luciferase reporter vector (pmirGLO-
SMAD7-WT) was constructed by amplifying 3’UTR of
the SMAD7 gene and then cloning them into the Hind III
and Spe I sites of pmirGLO-control vector and amplified
in chemically competent DH5α. Site-directed mutagenesis
kit (Promega) were used to made the mutant type of
SMAD7 3’UTR luciferase reporter vector (pmirGLO-
SMAD7-MUT). All constructs were verified by sequen-
cing. MiR-424-5p mimics or control oligotides, 100 ng
Wang et al. Diagnostic Pathology  (2016) 11:88 Page 3 of 9
luciferase reporter plasmid were cotransfected into EC-1
cells in 6-well plates. After 24 h, cells were lysed and
luciferase activity was measured using a Dual-Luciferase
Reporter Assay System (Promega).
Statistical analysis
The database was determined by the SPSS 11.0 software
for analysis. Data were showed as mean ± SD. Student’s T-
test was always performed between two sets of data. The
criteria for T-test significance was based on the two-tailed
distribution and for paired or equal variance type. A
p-value of <0.05 was viewed as statistically significant.
Results
MiR-424-5p was down-regulated in ESCC tissues and ESCC
cell lines
The biological roles of miR-424-5p in ESCC progression
had not been fully delineated. To define the potential
role miR-424-5p, we detected the expression levels of
miR-424-5p in ESCC tissues and ESCC cell lines.
First, we compared the expression of miR-424-5p in
ESCC tissues (n = 32) and adjacent normal mucosa tis-
sue (n = 32). And the expression of miR-424-5p was sig-
nificantly decreased in ESCC tissues (Fig. 1a). To further
explore the clinical value of miR-424-5p expression, the
relation between the expression of miR-424-5p and clini-
copathological parameters of patients with ESCC were
investigated. As shown in Table 1, expression levels of
miR-424-5p did not appear association with gender, age
or invasion depth (p > 0.05). Nevertheless the expression
of miR-424-5p was negatively linked to differentiation
and lymph node metastasis (p > 0.05). So in ESCC tis-
sues, we came to the conclusion that down-regulated
miR-424-5p had a negative trend with the invasion and
metastasis of ESCC.
To further confirm the low-expression trend of miR-
424-5p in the ESCC tissues, the expression of miR-424-
5p was detected by quantitative real-time PCR in ESCC
cell lines(EC9706, Eca-109, EC-1) and SHEE cells (im-
mortal embryonic esophageal epithelium). Although
miR-424-5p expression could be found in three ESCC
cell lines, their expression were all significantly lower
than that in SHEE cells (p < 0.05) (Fig. 1b). Thus, these
results demonstrated that miR-424-5p was also signifi-
cantly down-regulated in ESCC cell lines. We chose EC-
1 cells which showed the lowest miR-424-5p expression
for further experiments in this study.
Fig. 1 Downregulation of miR-424-5p in ESCC tissues and cell lines. a The expression levels of miR-424-5p were analyzed in ESCC tissues (T) and
adjacent normal mucosa tissues (N) by real-time PCR method, RNU6B levels were used as an internal control. And the results of real-time
PCR assay revealed down-regulation of miR-424-5p in ESCC tissue compare with adjacent normal mucosa tissues. **p < 0.01. b The expression
levels of miR-424-5p were analyzed in ESCC cell lines (EC9706, Eca109 and EC-1) and immortal embryonic esophageal epithelium cell line (SHEE) by
real-time PCR method, RNU6B levels were used as an internal control. Expression of miR-424-5p was down-regulated in EC9706, Eca109 and EC-1
compared with SHEE. **p < 0.01. The expression of miR-424-5p in EC-1 was the lowest in three kinds of ESCC cell lines although there had no statistical
difference among them
Table 1 Relationship between miR-424-5p expression and
clinico-pathological parameters
Clinico-pathological parameters Number Mean ± SD p value
Age (years)
≥ 60 25 9.36 ± 3.20 0.421
< 60 7 9.82 ± 2.91
Gender
Male 19 8.96 ± 2.79 0.518
Female 13 9.43 ± 3.01
Depth of invasion
Superficial 12 10.85 ± 1.77 0.018
Deep 20 7.32 ± 0.97
Lymph node metastasis
No 14 11.66 ± 2.95 0.006
Yes 18 7.11 ± 2.62
Differentiation
Well differentiated 17 10.09 ± 2.32 0.095
Moderately/poorly differentiated 15 9.73 ± 1.69
The miR-424-5p expression was associated with depth of invasion and lymph
node metastasis. P < 0.05
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Overexperssion of miR-424-5p inhibited EC-1 cells invasion
and metastasis
To validate the function of miR-424-5p, we transient
transfected miR-424-5p mimics (mimic the endogenous
mature miR-424-5p function) or control oligotides into
EC-1 cell. Forty-eight hours after transfection, miR-424-
5p expression in EC-1 cells showed a dramatically in-
crease compared to that in negative control or blank
control (p < 0.05) (Fig. 2a). No statistical significance of
miR-424-5p expression was found between the negative
and blank control groups (p > 0.05). These results indi-
cated that miR-424-5p mimics could regulate miR-424-
5p expression effectively in EC-1 cells.
As mentioned above, the expression levels of miR-424-
5p were negatively correlated with differentiation and
lymph node metastasis in ESCC tissues. To further study
on the influence of miR-424-5p on EC-1 invasion and
metastasis ability, then several functional analyses were
performed. The results of transwell invasion assay
showed that overexpression of miR-424-5p significantly
decreased the invasiveness of EC-1 cells compared to
those in control groups (p < 0.05) (Fig. 2b). Furthermore,
the wound healing ability of EC-1 cells transfected
with miR-424-5p mimics were also decreased greatly
(p < 0.05) (Fig. 2c). These results showed that miR-1195
might be an important element inhibiting invasion and
metastasis of EC-1 cells.
Overexperssion of miR-424-5p inhibited ESCC cells growth
Inhibition of cell invasion and metastasis in cancer
cells is usually associated with cancer cells abnormal
growth. Here, we demonstrated the effects of miR-
424-5p on the proliferation of EC-1 cells after trans-
fected with miR-424-5p mimics. And the results of cell
proliferation assay showed that in EC-1 cells, starting
at 48 h, there was an decrease in cell proliferation with
Fig. 2 Overexperssion of miR-424-5p inhibited EC-1 cells invasion and metastasis. a Real-time PCR analysis of miR-424-5p in EC-1 cells transfected
with miR-424-5p mimics showed increased miR-424-5p expression compared with EC-1 cells transfected with those in negative control or blank
control. **p < 0.01. b The results of cell invasion assay showed that the average number of invasive cells in miR-424-5p mimics groups were
greatly lower than those in negative control or blank control. *p < 0.05. Representative fields of invasive cells on the membrane were shown.
c The results of wound healing assay also showed that the wound healing ability of EC-1 cells transfected with miR-424-5p were significantly
increased compared with EC-1 cells transfected with those in negative control or blank control. *p < 0.05. Representative pictures of wound
healing distance were shown
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overexpression of miR-424-5p relative to negative or blank
control (p < 0.05) (Fig. 3). These data suggested a specific
role for miR-424-5p in driving EC-1 cells proliferation.
MiR-424-5p targets SMAD7 leading to inhibition of the
TGF-β-SMAD7 pathway
MiR-424-5p was frequently down–regulated in ESCC
and was a key factor in cell invasion, metastasis and pro-
liferation as demonstrated above. We then observed the
molecular mechanism of miR-424-5p mediated bio-
logical function. We examined its potential targets by
searching Targetscan database and PicTar and found that
among the candidate targets, the 3’-UTR of SMAD7
contained the miR-424-5p conserved binding site
(ACGACGA). Furthermore, in order to examine whether
SMAD7 was a functional target of miR-424-5p, we
evaluated the reporter activity in cells co-transfected with
miR-424-5p mimics (or negative control) and pmirGLO-
SMAD7-WT (or pmirGLO-SMAD7-MUT). As shown in
Fig. 4a, EC-1 cells co-transfected with miR-424-5p mimics
and pmirGLO-SMAD7-WT demonstrated a significant
decrease of reporter activity in comparison with those co-
transfected with negative control and pmirGLO-SMAD7-
WT(p < 0.05). In addition, EC-1 cells co-transfected with
miR-424-5p mimics and pmirGLO-SMAD7-MUT or
negative control and pmirGLO-SMAD7-MUT showed no
significant decrease of reporter activity in comparison
with those co-transfected with negative control and
pmirGLO-SMAD7-MUT(p > 0.05). Taken together, lucif-
erase activity of wild-type SMAD7-3’-UTR but not
mutated SMAD7-3’-UTR reporter was decreased by miR-
424-5p mimic in EC-1 cells. Furthermore, the western blot
assay and real-time PCR analyses revealed that SMAD7
protein and mRNA expression were greatly decreased in
miR-424-5p mimics transfected EC-1 cells (Fig. 4b). All
these results revealed that SMAD7 is a target of miR-424-
5p in ESCC.
The SMAD7 signaling pathway is known to facilitate
metastasis in advanced malignancy by taking part in
EMT processes. In the present study, two major genes:
E-cadherin and vimentin involved the EMT processes
were also analyzed by western blot and real-time PCR.
As shown in Fig. 4c, the mRNA and protein expression
of E-cadherin were increased in EC-1 cells transfected
with miR-424-5p mimics while the mRNA and protein
expression of vimentin were decreased compared to
those in negative or blank control (all p < 0.05). These
data elucidated to us that miR-424-5p could participate
in EMT in ESCC cells and perhaps this participation
were mediated by the SMAD7 signaling pathway.
Overexpression of SMAD7 could partially enhance the
EMT weaken by higher expression of MiR-424-5p
In order to give further proof of the role of SMAD7 sig-
naling pathway in miR-424-5p involved EMT, SMAD7
eukaryotic expression vector pcDNA3.1-SMAD7 was
transfected into EC-1 cells for 48 h after the EC-1 cells
were treated with miR-424-5p mimics or control oligo-
tides. As shown in Fig. 5a, b, the overexpression of
SMAD7 could partially reverse the expression of E-
caherin and vimentin treated with miR-424-5p mimics.
Thus, our results further proved that SMAD7 signaling
pathway participated in the miR-424-5p regulated EMT
in esophageal squamous cell carcinoma.
Discussion
Lately, miRNAs have been shown to regulate tumor in-
vasion, metastasis, providing for us a new view on the
invasion process [18]. MiR-424-5p had been showed to
participate in various cellular processes especially the in-
vasion and metastasis processes [12]. Nonetheless, there
had been no reports on the expression and role of miR-
424-5p in ESCC.
In this study, the expression of miR-424-5p was exam-
ined in paraffin-embedded blocks. We showed that the
expression of miR-424-5p were greatly lower in ESCC
tissues compared with those in adjacent normal mucosa
tissues. Furthermore, the three kinds of ESCC cell lines
(EC9706, Eca109 and EC-1) we chose were also showed
lower expression levels of miR-424-5p compared to that
in SHEE cells, stating clearly that the loss of miR-424-5p
might be a common event in tumorigenesis. Strikingly,
the expression of miR-424-5p were also greatly lower in
ESCC tissues with lymph node metastasis, compared to
that without lymph node metastasis, indicating that the
expression of miR-424-5p might be negatively linked to
metastasis in ESCC.
Based on these, we supposed that miR-424-5p might
play an important role as a tumor suppressor in the
Fig. 3 Overexperssion of miR-424-5p inhibited EC-1 cells proliferation
ability. MTT viability assays were performed 24, 48 and 72 h after
the transfection of miR-424-5p. And the results showed that the
proliferation ability of EC-1 cells transfected with miR-424-5p
were greatly lower than those in negative control or blank control.
**p < 0.01, *p < 0.05
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invasion and metastasis in ESCC. We then performed
functional analyses to study on the role of miR-424-5p
in the invasion and metastasis ability of EC-1 cells
(expressed the lowest miR-424-5p levels in the three
kinds of ESCC lines) transfected with miR-424-5p
mimics. As expected, in our real-time PCR analysis of
the EC-1 cells, miR-424-5p expression was markedly up-
regulated in EC-1 cells transfected with miR-424-5p
mimics compared to those in negative and blank control.
In addition, miR-424-5p overexpression dramatically
inhibited EC-1 cells invasion and metastasis ability. Cell
proliferation ability of EC-1 cells transfected with miR-
424-5p mimics was also decreased. These results further
validated our suggestion that miR-424-5p might function
as a tumor suppressor and played an important role in
inhibition on the invasion and metastasis of ESCC cells.
Fig. 4 MiR-424-5p targeted SMAD7 by binding to its 3’UTR. a The SMAD7 3’UTR was a potential target of miR-424-5p. MiR-424-5p mimics decreased
luciferase activities controlled by wild-type SMAD7-3’UTR *p < 0.05, while did not influence the luciferase activities controlled by mutant SMAD7-3’UTR
or miR-424-5p negative control. b SMAD7 mRNA and protein expression in EC-1 cells transfected with miR-424-5p mimics were detected by real-time
PCR and western blot assay 48 h after transfection, EC-1 cells transfected with control oligotides or vacant EC-1 cells were used as negative or blank
controls respectively. β-actin was used as an internal control. And the results showed that the mRNA and protein expression of SMAD7 were
significantly decreased compared to those in control groups. *p < 0.05. c Expression of miR-424-5p mimics also enhanced the expression of
E-cadherin and suppressed the expression of vimentin. *p < 0.05
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By detecting the expression of miR-424-5p can perhaps
help us to tell the possibility of invasion and metastasis.
As part of our research on how the down-regulation
of miR-424-5p influenced EC-1 cells invasion and me-
tastasis, we used TargetScan and PicTar to identify target
genes of miR-424-5p. This approach allowed us to verify
SMAD7 as a potential target of miR-424-5p. We per-
formed 3’UTR luciferase assay, and observed that lucif-
erase activity was decreased after co-transfection of
miR-424-5p mimics and a pmirGLO-SMAD7-WT. We
also demonstrated that restoration of miR-424-5p ex-
pression levels tightly regulated SMAD7 expression and
further confirmed that SMAD7 as a direct target of
miR-424-5p. SMAD7 was initially isolated as an onco-
gene and was the downstream mediator of transforming
growth factor beta (TGF-β), which is an important
multifunctional cytokine that regulates cell proliferation
and progression [19–21]. TGF-β-SMAD7 signaling
pathway has been showed to be a key signaling pathway
of epithelial-mesenchymal transition (EMT) in cancers
[22, 23]. EMT was viewed as the first step in cancer
invasion and metastasis, a number of evidences had re-
cently confirmed that some microRNAs were involved
in this process [24]. In the current study, we demon-
strated that with the restoration of miR-424-5p, the ex-
pression of epithelial marker E-cadherin which was also
a hall marker of the occurrence of EMT was increased
while the expression of mesenchymal marker vimentin
decreased. In addition, overexpression of SMAD7 could
enhance the EMT weakened by miR-424-5p mimics.
These results indicated that miR-424-5p could also take
part in EMT in ESCC cells and miR-424-5p perhaps
participated in EMT in ESCC cells via the SMAD7 sig-
naling pathway.
Conclusion
Our data indicated that down-regulated miR-424-5p was
implicated in ESCC tissues and cell lines, particularly in
ESCC tissues with lymph node metastasis. In addition, we
demonstrated the function role of miR-424-5p in invasion
and metastasis in EC-1 cells by up-regulating miR-424-5p
expression levels in EC-1 cells. Finally, we elucidated over-
expression of miR-424-5p decreased EC-1 cells invasion
and metastasis through mechanisms involving SMAD7
signaling pathway and EMT. We are now investigating the
role of SMAD7 signaling pathway in miR-424-5p medi-
ated EMT and the potential role of miR-424-5p as prog-
nostic and predicative biomarkers in ESCC.
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